Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance

Details for Australian Patent Application No. 2003240100 (hide)

Owner AstraZeneca AB

Inventors Li, Lanna

Agent Davies Collison Cave

Pub. Number AU-B-2003240100

PCT Number PCT/GB03/02591

PCT Pub. Number WO2004/000294

Priority 0201936-2 20.06.02 SE

Filing date 17 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 1 June 2006

International Classifications

A61K 31/19 (2006.01)

C07C 235/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 323/62 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0201936-2 20.06.02 SE

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003240100

1 June 2006 Application Accepted

  Published as AU-B-2003240100

28 September 2006 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240101-Benzoic acid derivatives as modulators of PPAR alpha and gamma

2003240099-Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance